As the healthcare landscape rapidly evolves, challenges related to medication access and affordability come to the forefront. Direct-to-consumer models reduce reliance on traditional intermediaries, such as in-person clinical visits, retail pharmacies, and insurance companies, but they also raise new risks and considerations.
Download our white paper: Click, Prescribe, Deliver: The New Era of Direct-to-Consumer Pharmaceutical Care and discover how Shields Health Solutions bridges the gap between health systems and the patients they serve.
Inside, you’ll learn:
Defining features of DTC care models, including virtual intake and online prescribing
Key risks and limitations of the DTC care model, particularly for GLP-1 RA and GIP/GLP-1 RA prescriptions
A comparison of medication adherence rate and out-of-pocket (OOP) costs between DTC models and integrated specialty pharmacy care
Discover how integrated specialty pharmacy care drives better access, affordability, and adherence.